Please click the links below to download PDF versions of the following documents:
AMJEVITA™ Prescribing Information
AMJEVITA™ Patient Instructions for Use
This is not an offer for sale. AMJEVITA™ is currently not available commercially and will not be commercially available in the United States until on or after January 31, 2023.
Healthcare professionals can visit www.amgenmedinfo.com, call the Amgen Medical Information hotline (800-77-AMGEN), or email medinfo@amgen.com to request medical information and to report an adverse event or product complaint.
Click the button below to sign up to receive updates about Amgen Biosimilars. To learn more about what biosimilars are, visit our page for patient education on biosimilars.